Stock listing

Pharmaron Beijing Co., Ltd. Class A

Selected listing: 300759 · SZSE · CNY · CN

Pharmaron Beijing Co., Ltd. Class A (Shenzhen:300759), Health Technology. Latest release Oct 28, 2025: Pharmaron Acquires Biortus in China.

300759:SZSECNYCNUpdated October 2, 2026

Ticker: Shenzhen:300759
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Shenzhen
Currency: CNY

About Pharmaron Beijing Co., Ltd. Class A

Pharmaron Beijing Co., Ltd. Class A is a public company listed on the Chinese stock market under the ticker 300759. The company focuses on drug discovery, development, and manufacturing, contributing to advancements in healthcare.

Latest news from Pharmaron Beijing Co., Ltd. Class A

Pharmaron Acquires Biortus in China

October 28, 2025

Pharmaron’s Liverpool UK Gene Therapy CDMO Commences Major Site Expansion Following UK Government Grant to Support £151m Investment

March 29, 2023

Pharmaron Acquires Commercial API Manufacturing Facility in the United States

May 24, 2022

Pharmaron Appoints Dr. Antony Davies as Senior Vice President, UK CMC

January 16, 2022

Pharmaron Acquires Commercial API Manufacturing Facility in the United Kingdom from Recipharm

January 9, 2022

All Pharmaron Beijing Co., Ltd. Class A news →

Research Pharmaron Beijing Co., Ltd. Class A

Pharmaron Beijing Co., Ltd. Class A company profile

View the public company page for Pharmaron Beijing Co., Ltd. Class A on 6ix.

Pharmaron Beijing Co., Ltd. Class A news

Read company news and market updates connected to Pharmaron Beijing Co., Ltd. Class A.

Pharmaron Beijing Co., Ltd. Class A investor events

Find investor webinars, events, and replay context for Pharmaron Beijing Co., Ltd. Class A.